Cargando…
GPRC5D as a promising therapeutic target in EGFR-wild and immuno-cold non-small cell lung cancer
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10424388/ https://www.ncbi.nlm.nih.gov/pubmed/37574551 http://dx.doi.org/10.1186/s12967-023-04415-w |
_version_ | 1785089665695481856 |
---|---|
author | Mei, Jie Cai, Yun Jiang, Guanyu He, Zhao Wang, Ruixin Song, Chenghu Wan, Yuan Mao, Wenjun |
author_facet | Mei, Jie Cai, Yun Jiang, Guanyu He, Zhao Wang, Ruixin Song, Chenghu Wan, Yuan Mao, Wenjun |
author_sort | Mei, Jie |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10424388 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-104243882023-08-15 GPRC5D as a promising therapeutic target in EGFR-wild and immuno-cold non-small cell lung cancer Mei, Jie Cai, Yun Jiang, Guanyu He, Zhao Wang, Ruixin Song, Chenghu Wan, Yuan Mao, Wenjun J Transl Med Letter to the Editor BioMed Central 2023-08-13 /pmc/articles/PMC10424388/ /pubmed/37574551 http://dx.doi.org/10.1186/s12967-023-04415-w Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Letter to the Editor Mei, Jie Cai, Yun Jiang, Guanyu He, Zhao Wang, Ruixin Song, Chenghu Wan, Yuan Mao, Wenjun GPRC5D as a promising therapeutic target in EGFR-wild and immuno-cold non-small cell lung cancer |
title | GPRC5D as a promising therapeutic target in EGFR-wild and immuno-cold non-small cell lung cancer |
title_full | GPRC5D as a promising therapeutic target in EGFR-wild and immuno-cold non-small cell lung cancer |
title_fullStr | GPRC5D as a promising therapeutic target in EGFR-wild and immuno-cold non-small cell lung cancer |
title_full_unstemmed | GPRC5D as a promising therapeutic target in EGFR-wild and immuno-cold non-small cell lung cancer |
title_short | GPRC5D as a promising therapeutic target in EGFR-wild and immuno-cold non-small cell lung cancer |
title_sort | gprc5d as a promising therapeutic target in egfr-wild and immuno-cold non-small cell lung cancer |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10424388/ https://www.ncbi.nlm.nih.gov/pubmed/37574551 http://dx.doi.org/10.1186/s12967-023-04415-w |
work_keys_str_mv | AT meijie gprc5dasapromisingtherapeutictargetinegfrwildandimmunocoldnonsmallcelllungcancer AT caiyun gprc5dasapromisingtherapeutictargetinegfrwildandimmunocoldnonsmallcelllungcancer AT jiangguanyu gprc5dasapromisingtherapeutictargetinegfrwildandimmunocoldnonsmallcelllungcancer AT hezhao gprc5dasapromisingtherapeutictargetinegfrwildandimmunocoldnonsmallcelllungcancer AT wangruixin gprc5dasapromisingtherapeutictargetinegfrwildandimmunocoldnonsmallcelllungcancer AT songchenghu gprc5dasapromisingtherapeutictargetinegfrwildandimmunocoldnonsmallcelllungcancer AT wanyuan gprc5dasapromisingtherapeutictargetinegfrwildandimmunocoldnonsmallcelllungcancer AT maowenjun gprc5dasapromisingtherapeutictargetinegfrwildandimmunocoldnonsmallcelllungcancer |